More chaos for InVivo as CFO leaves
This article was originally published in Clinica
Executive Summary
InVivo Therapeutics’ share price has slumped again, after CFO Sean Moran quit and the company cancelled plans to present at the annual Rodman and Renshaw Healthcare Conference in New York. Its stock fell 23% to close at $1.57 on 10 September, the day after the announcement.